ACS has a dedicated interest in clinical research. Since 1991 the Research Department at ACS has been conducting investigative clinical trials encompassing therapies for prevention as well as treatment of acute and chronic cardiovascular diseases.
The ACS Research Department is a nationally and internationally reputed research site that has been an active and leading participant in over 120 multicenter trials by the FDA. These trials specifically target patients who have complex coronary heart disease, left ventricular dysfunction, heart failure and arrhythmias. The cardiologists, internists and surgeons at ACS are actively involved in these research trials.
If you are interested in learning more about our clinical trials or would like more information, please contact the Research Department at (480)-545-1847
ACCESS: Transcatheter (non-surgical) closure of patent foramen ovale ("hole in the heart") in patients with unexplained strokes / ministrokes.
AMGEN / (RED-HF™): Drug trial in patients who have anemia with symptomatic left ventricular systolic dysfunction.
EXAMINE/TAKEDA: Drug trial for patients with type 2 Diabetes Mellitus and Chest pain.
PROMISE: This National Institutes of Health (NIH) trial that randomizes patients with new symptoms of chest pain/Angina, choosing standard community evaluation versus direct imaging of coronary arteries via the new General Electric 64-slice CT scanner that images heart vessel blockages, if present.
SAPPHIRE: Carotid stent trial for patients at high risk for surgical therapy
TAXUS Liberte: Coronary artery stent with dual anti-platelet treatment.
ACCESS: Transcatheter (non-surgical) closure of patent foramen ovale ("hole in the heart") in patients with unexplained strokes / ministrokes.
AMGEN / (RED-HF™): Drug trial in patients who have anemia with symptomatic left ventricular systolic dysfunction.
CYPRESS /Cypher: Coronary artery stents with dual anti-platelet therapy combination.
EXAMINE/TAKEDA: Drug trial in patients who have diabetes type II and heart disease.
OVATIO CRT: Biventricular device trials in patients with advanced heart failure.
PROMISE: This National Institutes of Health (NIH) trial that randomizes patients with new symptoms of chest pain/Angina, choosing standard community evaluation versus direct imaging of coronary arteries via the new General Electric 64-slice CT scanner that images heart vessel blockages, if present.
SAPPHIRE: Carotid stent trial for patients at high risk for surgical therapy.
TAXUS Liberte: Coronary artery stent with dual anti-platelet treatment.
This data has served us well in terms of monitoring and modifying the quality of care we provide to our patients. It has also served the international medical / scientific community well and has resulted in over 100 presentations in the past eight years, at international scientific conferences in the U.S., Canada, Europe and Asia. The scientific forums have included the American College of Cardiology, American Heart Association, Society of Cardiac Angiography & Intervention, European Society of Cardiology, Heart Failure Society of America and the World Congress of Cardiology.